Published August 2004 | Version v1
Journal article

Clinical significance of measurement of changes of serum IL-2, SIL-2R levels after chemotherapy in patients with lung carcinoma

  • 1. Zhenjiang First People's Hospital, Zhenjiang, Jiangsu (China). Dept. of Nuclear Medicine

Description

Objective: To study the changes of serum IL-2 and SIL-2R levels after chemotherapy in 36 patients with lung carcinoma. Methods: Serum IL-2 (with RIA) and SIL-2R (with ELISA) levels were measured in 36 patients with lung carcinoma both before and after chemotherapy as well as in 35 controls. Results: Before chemotherapy, in the patients the serum IL-2 levels were significantly lower and serum SIL-2R levels were significantly higher than those in the controls (P<0.01). Six months after chemotherapy, those patients without recurrence (n=20) had their IL-2 and SIL-2R levels returned to normal but in those with recurrences (n=12) the levels were about the same as before. Conclusion: Cytokines IL-2 and SIL-2R levels changes could reflect the immunostatus of the patient as well as the progress of disease and could be of prognostic value. (authors)

Additional details

Publishing Information

Journal Title
Journal of Radioimmunology
Journal Volume
17
Journal Issue
4
Journal Page Range
p. 255-256
ISSN
1008-9810

Optional Information

Notes
2 tabs., 8 refs.